The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
 
Rui-hua Xu
No Relationships to Disclose
 
Zhi-Qiang Wang
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Jian-Wei Lu
No Relationships to Disclose
 
Guanghai Dai
No Relationships to Disclose
 
Jian-Ming Xu
No Relationships to Disclose
 
Yan-Qiao Zhang
No Relationships to Disclose
 
Xiao-Bing Chen
No Relationships to Disclose
 
Yan-Hong Deng
No Relationships to Disclose
 
Yun-Bo Zhao
No Relationships to Disclose
 
Nan-Feng Fan
No Relationships to Disclose
 
Gengsheng Yu
No Relationships to Disclose
 
Wangjun Liao
No Relationships to Disclose
 
Xia Yuan
No Relationships to Disclose
 
You-En Lin
No Relationships to Disclose
 
Guo-Long Liu
No Relationships to Disclose
 
Qing-Feng Zou
No Relationships to Disclose